Table 1 Baseline characteristics of nasopharyngeal carcinoma patients with and without critical weight loss
From: Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma
Characteristics | Non-critical weight loss (N = 1056) | Critical weight loss (N = 1343) | P |
|---|---|---|---|
Age (y) media (range) | 45 (13–78) | 46 (13–78) | 0.004 |
Gender (%) | Â | Â | Â |
 Male | 817 (77.4) | 1009 (75.1) | 0.202 |
 Female | 239 (22.6) | 334 (24.9) |  |
Clinical stage (%) | Â | Â | Â |
 I-II | 476 (45.1) | 489 (36.4) | <0.001 |
 III-IV | 580 (54.9) | 854 (63.6) |  |
T-stage (%) | Â | Â | Â |
 T1-2 | 648 (61.4) | 745 (55.5) | 0.004 |
 T3-4 | 408 (38.6) | 598 (44.5) |  |
N-stage (%) | Â | Â | Â |
 N0-1 | 744 (70.5) | 841 (62.6) | <0.001 |
 N2-3 | 312 (29.5) | 502 (37.4) |  |
Treatment group (%) | Â | Â | Â |
 RT | 547 (51.8) | 519 (38.6) | <0.001 |
 CRT | 509 (48.2) | 824 (61.4) |  |
Smoking status (%) | Â | Â | Â |
 never-smokers | 552 (52.3) | 697 (51.9) | 0.856 |
 ex-smokers | 504 (47.7) | 646 (48.1) |  |
RT dose (Gy), media (range) | 70 (60–87) | 70 (60–86) | 0.127 |
BMI (kg/m2), media (range) | 22.04 (14.04–35.36) | 22.77 (13.61–39.06) | <0.001 |